RWRyan Wereski

Ryan Wereski

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ryan Wereski has a total of 260 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of Lipoprotein(a) and Low-Attenuation Plaque Burden With Future Myocardial Infarction

    by Daniel Isenstein, Mohammed N. Meah, Andrew R. Chapman, Takeshi Fujisawa, Damini Dey, Marc R. Dweck, Nicholas L. Mills, David E. Newby, Michelle C. Williams, Ryan Wereski

  • Open Access

    Single-Sample Rule-Out Pathway for Acute Myocardial Infarction Using a High-Sensitivity Cardiac Troponin I Assay

    by Ziwen Li, Takeshi Fujisawa, Øyvind Skadberg, Alexander J F Thurston, Yong Yong Tew, Kristin M Aakre, Nicholas L Mills, Ryan Wereski, Jennifer Blades, Ross Campbell, et al.

  • Open Access

    Evaluation of risk stratification at presentation using the Alinity high-sensitivity cardiac troponin I assay

    by Ziwen Li, Takeshi Fujisawa, Oyvind Skadberg, Paul Fineran, Alexander Jf Thurston, Yong Yong Tew, Kristin Moberg Aakre, Nicholas L Mills, Ryan Wereski, the POC-ET Investigators

    : Background: High-sensitivity cardiac troponin (hs-cTn) assays enable safe early discharge of patients at very low risk for myocardial infarction. We previously developed a single-sample rule-out pathway using the ARCHITECT hs-cTnI assay to risk stratify patients with suspected acute coronary syndrome. In a secondary analysis of the POC-ET (Point of Care Evaluation of High-sensitivity Cardiac Troponin) study, we evaluated performance of risk stratification with the Alinity hs-cTnI assay. Methods: Patients presenting with possible myocardial infarction in the POC-ET ( NCT05665127 ) study were included. The primary outcome was type 1, 4b or 4c myocardial infarction or cardiac death at 30 days. Cardiac troponin I (cTnI) was measured in stored materials using the ARCHITECT and Alinity hs-cTnI assays. The sex-specific 99 th percentile upper reference limit (URL) are 34 ng/L in men and 16 ng/L in women for both assays. Agreement was assessed with Bland-and-Altman limit of agreement method, Passing Bablok regression, and Pearson’s correlation coefficient. Distributions of presentation measurements were compared with Kolmogorov-Smirnov test. Performance was evaluated in the overall population and prespecified subgroups. The negative predictive value (NPV) and sensitivity were determined and proportion of patients identified as low, intermediate, and high risk were calculated and modelled using ordinal logistic regression. Results: In 986 patients (60 [51-70] years, 38% female), 78 (7.9%) had a primary outcome. Strong agreement was found in the raw cTnI measurements (99% samples within the Bland-Altman limit of agreement; correlation coefficient: 0.967 (95% CI 0.964-0.969, P ); Passing Bablok regression: slope 1.12 [1.11-1.13], intercept-0.16 [-0.18 to-0.13]). At presentation, distributions of cTnI measurements by the two assays were similar ( P=0.810 ). Both assays showed comparable diagnostic performance using a risk stratification threshold of versu s ARCHITECT 100 [99.7-100]%) and sensitivity (Alinity 100 [97.3-100]% versus ARCHITECT 100 [97.3-100]%). Similar proportions of patients stratified as low-(Alinity 67% versus ARCHITECT 67%), intermediate-risk (23% versus 24%) and high-risk (10% versus 9%) at presentation with minor reclassification. Similar efficacy was observed across subgroups stratified by sex, age, history of myocardial infarction, renal function, and symptom duration. Conclusions: The Alinity hs-cTnI and the ARCHITECT hs-cTnI assays can be used interchangeably in the assessment of suspected myocardial infarction with comparable safety and efficacy.

  • Open Access

    Impact of local and national policies to reduce agriculture-related air pollution through improving diet and farm management: the AMPHoRA mixed methods study

    by Stefan Reis, Rachel Beck, Ed Carnell, Ulrike Dragosits, Rosemary Green, Mike Holland, Megan Jones, Scott Jones, Alison McCann, Mark Miller, et al.

    Methods: This study employed an interdisciplinary approach to assess the impact of agricultural production modifications and dietary changes on ammonia emissions, health outcomes and health inequalities. Statistical and econometric methods were applied to analyse agricultural emission trends and dietary patterns. Spatial data analysis and numerical modelling techniques were used to simulate the dispersion and transformation of atmospheric pollutants. Health impact modelling estimated mortality and morbidity outcomes under various policy scenarios, while cost-effectiveness and cost–benefit analyses supported decision-making. A participatory approach involving multistakeholder engagement was utilised to enhance policy relevance and implementation feasibility. A systematic scoping review of academic studies on agricultural-derived air pollution and clinically coded outcomes revealed very limited research on this topic, which presents an inconsistent picture as to whether agricultural-derived particulate matter affects health. Results: Key findings indicate that dietary modifications have greater potential health benefits than direct reductions in particulate matter exposure from ammonia emissions. Small reductions in meat and dairy consumption, supported by taxation and subsidies, could help achieve environmental and health targets. A 20% meat and dairy tax, coupled with a 20% subsidy on fruits and vegetables, could reduce meat consumption by 21.5% and increase fruit and vegetable intake by up to 13.5%. These dietary shifts also significantly lower greenhouse gas emissions and water use. While ammonia’s environmental effects are well documented, its direct health impacts remain uncertain. Epidemiological studies suggest a possible association between ammonium-derived particulate matter and increased mortality and cardiorespiratory diseases, though findings are inconsistent. Toxicological assessments indicate limited intrinsic toxicity of ammonium nitrate and sulfate. A ‘high-ambition mitigation’ scenario integrating ammonia reduction measures with dietary shifts could prevent 67,000 premature deaths and 270,000 cases of respiratory diseases over 30 years. Notably, older adults and lower-income populations would experience the greatest health benefits. Most farm-based ammonia reduction strategies demonstrated net economic benefits, with only a few measures having limited abatement potential. Additionally, reduced greenhouse gas emissions further amplified the benefits of each scenario. Limitations: Despite robust modelling techniques and multistakeholder engagement, several limitations exist. The direct health effects of ammonia-derived particulate matter remain an area of uncertainty, necessitating further epidemiological research. Additionally, while economic and environmental benefits were quantified, behavioural responses to policy interventions – such as consumer acceptance of dietary changes – require further exploration. The study primarily focused on UK-specific data, limiting generalisability to other regions with different agricultural practices and policy landscapes. Finally, unintended consequences of dietary shifts on food security and cultural preferences were not fully explored, indicating the need for future research to refine policy recommendations. The Assessing Mitigation Pathways to Realise Public Health Benefits of Air Pollutant Emission Reductions from Agriculture project provides a comprehensive, interdisciplinary framework for evaluating integrated policy measures. It underscores the importance of sustainable agricultural and dietary transitions in achieving cobenefits for public health and environmental sustainability, while emphasising the need for continued research to address remaining uncertainties. Future work: More detailed spatial and temporal analyses are required to fully understand the potential importance of significant local sources on human health in specific areas/times of year. There is a need to better align evidence of studies, such as Assessing Mitigation Pathways to Realise Public Health Benefits of Air Pollutant Emission Reductions from Agriculture, with toxicological studies which suggest that (pure) ammonium nitrate and sulfate have only very modest toxicity. Study registration: This study is registered as PROSPERO CRD42020172116. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme (NIHR award ref: NIHR129440) and is published in full in Public Health Research ; Vol. 14, No. 3. See the NIHR Funding and Awards website for further award information.

  • Safety of Using Risk Stratification Along With High-Sensitivity Cardiac Troponin in the Emergency Department

    by Ziwen Li, Dimitrios Doudesis, Anda Bularga, Ryan Wereski, Caelan Taggart, Matthew T.H. Lowry, Andrew R. Chapman, Chris Tuck, Amy V. Ferry, Alasdair Gray, et al.


  • Unstable Angina Refined

    by Ryan Wereski, David A. Morrow, Nicholas L. Mills

  • Open Access

    Targeting Investigation and Treatment in Type 2 Myocardial Infarction

    by Caelan Taggart, Amy Ferry, Stephanie Barker, Kelly Williams, Grace Souter, Anda Bularga, Ryan Wereski, Michael J. McDermott, Michelle C. Williams, Jasper Boeddinghaus, et al.


  • Reply

    by Ziwen Li, Ryan Wereski, Nicholas L. Mills, Dorien M. Kimenai


  • Reply

    by Ryan Wereski, Andrew R. Chapman, Nicholas L. Mills

  • High-Sensitivity Cardiac Troponin for Risk Assessment in Patients With Chronic Coronary Artery Disease

    by Ryan Wereski, Philip Adamson, Nur Shazlin Shek Daud, Michael McDermott, Caelan Taggart, Anda Bularga, Dorien M. Kimenai, Mathew T.H. Lowry, Chris Tuck, Atul Anand, et al.